Search Results - Xiaoyu Lyu

Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials by Junlong Zhuang, Junlong Zhuang, Yuwen Wang, Yuwen Wang, Shun Zhang, Shun Zhang, Yao Fu, Haifeng Huang, Haifeng Huang, Xiaoyu Lyu, Xiaoyu Lyu, Shiwei Zhang, Shiwei Zhang, Giancarlo Marra, Linfeng Xu, Linfeng Xu, Xuefeng Qiu, Xuefeng Qiu, Hongqian Guo, Hongqian Guo, Hongqian Guo

Connect to this object online.